Wednesday, July 8, 2026

Patent intelligence · US

US 8734857

Hydrolysates made of plant extracts and antibacterial agent containing the same

granted A61KA61K36/185A61K36/35A61K36/51
Status granted
Linked drugs 1
Pipeline programs 6
Years to expiry 8
Applicant portfolio 52
Patent details — US 8734857
Jurisdiction
US
Status
granted
Grant date
May 27, 2014
Expiration
May 22, 2034
Applicant
BIONORICA SE
Claims
18
CPC classes
A61K, A61K36/185, A61K36/35, A61K36/51
View on Google Patents ↗

Quick answer

US 8734857 (Hydrolysates made of plant extracts and antibacterial agent containing the same) is held by BIONORICA SE. Status: granted. Granted May 27, 2014. Expires May 22, 2034 (8 years remaining) — relevant for patent-cliff and LOE planning.

Key facts

Applicant
BIONORICA SE
Grant date
Expiration
Claims
18
CPC classes
A61K, A61K36/185, A61K36/35, A61K36/51, A61K36/515, A61K36/70

More from BIONORICA SE

Related pharmaceutical patents in our USPTO index.

  1. US 12312339

    Polo like kinase 4 inhibitors

    ORIC PHARMACEUTICALS, INC. · Expires May 22, 2045

    granted
  2. US 12239729

    TRPV3 agonists for the treatment of skin conditions

    Soricimed Biopharma Inc. · Expires Feb 27, 2045

    granted
  3. US 12054556

    Anti-PD-L1 antibody and use thereof

    Oricell Therapeutics Co., Ltd. · Expires Aug 1, 2044

    granted
  4. US 12018043

    CD73 inhibitors

    ORIC PHARMACEUTICALS, INC. · Expires Jun 20, 2044

    granted
  5. US 12005080

    Method for promoting proliferation of immune cells

    Oricell Therapeutics Co., Ltd. · Expires Jun 6, 2044

    granted
  6. US 11993655

    Anti-PD-L1 antibody and use thereof

    Oricell Therapeutics Co., Ltd. · Expires May 23, 2044

    granted
  7. US 11858915

    Polo like kinase 4 inhibitors

    ORIC PHARMACEUTICALS, INC. · Expires Dec 28, 2043

    granted
  8. US 11807658

    CD73 inhibitors

    ORIC PHARMACEUTICALS, INC. · Expires Nov 2, 2043

    granted

Frequently asked questions

What is US patent 8734857?

US 8734857 (Hydrolysates made of plant extracts and antibacterial agent containing the same) is held by BIONORICA SE. Status: granted. Granted May 27, 2014. Expires May 22, 2034 (8 years remaining) — relevant for patent-cliff and LOE planning.

Who owns US 8734857?

BIONORICA SE is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 52 pharmaceutical patents for this assignee.

When does US 8734857 expire?

Our index shows an expiration date of May 22, 2034 (8 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.